Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Liljas

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Journal of Health Economics|March 8, 1998
The demand for health with uncertainty and insuranceB Liljas
Pharmacoeconomics|December 8, 1997
How to calculate indirect costs in economic evaluationsB Liljas
Journal of Health Economics|February 24, 2001
Insurance and imperfect financial markets in Grossman's demand for health model--a reply to Tabata and OhkusaB Liljas
Pharmacoeconomics|June 1, 2001
On individual preferences and aggregation in economic evaluation in healthcareB Liljas, B Lindgren
Health Policy (Amsterdam, Netherlands)|July 19, 2000
On hypothetical bias and calibration in cost-benefit studiesB Liljas, K Blumenschein
Patient Education and Counseling|March 28, 1998
Is asthma self-management cost-effective?B Liljas, A Lahdensuo
Pharmacoeconomics|July 6, 1997
Cost-effectiveness analysis of a dry powder inhaler (Turbuhaler) versus a pressurised metered dose inhaler in patients with asthmaB Liljas, E Stådhl, R A Pauwels
Medical Care|August 26, 1998
The impact of risk information on patients' willingness to pay for autologous blood donationS J Lee, B Liljas, P J Neumann, et al.
International Journal of Technology Assessment in Health Care|May 18, 2000
Measuring costs in cost-utility analyses. Variations in the literatureP W Stone, R H Chapman, E A Sandberg, et al.
Controlled Clinical Trials|August 22, 2001
Design and analytic considerations in determining the cost-effectiveness of early intervention in asthma from a multinational clinical trialS D Sullivan, B Liljas, M Buxton, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Journal of Health Economics|March 8, 1998
The demand for health with uncertainty and insuranceB Liljas
Pharmacoeconomics|December 8, 1997
How to calculate indirect costs in economic evaluationsB Liljas
Journal of Health Economics|February 24, 2001
Insurance and imperfect financial markets in Grossman's demand for health model--a reply to Tabata and OhkusaB Liljas
Pharmacoeconomics|June 1, 2001
On individual preferences and aggregation in economic evaluation in healthcareB Liljas, B Lindgren
Health Policy (Amsterdam, Netherlands)|July 19, 2000
On hypothetical bias and calibration in cost-benefit studiesB Liljas, K Blumenschein
Patient Education and Counseling|March 28, 1998
Is asthma self-management cost-effective?B Liljas, A Lahdensuo
Pharmacoeconomics|July 6, 1997
Cost-effectiveness analysis of a dry powder inhaler (Turbuhaler) versus a pressurised metered dose inhaler in patients with asthmaB Liljas, E Stådhl, R A Pauwels
Medical Care|August 26, 1998
The impact of risk information on patients' willingness to pay for autologous blood donationS J Lee, B Liljas, P J Neumann, et al.
International Journal of Technology Assessment in Health Care|May 18, 2000
Measuring costs in cost-utility analyses. Variations in the literatureP W Stone, R H Chapman, E A Sandberg, et al.
Controlled Clinical Trials|August 22, 2001
Design and analytic considerations in determining the cost-effectiveness of early intervention in asthma from a multinational clinical trialS D Sullivan, B Liljas, M Buxton, et al.
Pageof 2